Medicure (MCUJF) Free Cash Flow Growth (3y) (2012 - 2026)
Medicure (MCUJF) Free Cash Flow Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.06 Bn | 87.19 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 9.86% |
| 3 | Zoetis | 32.39 Bn | 30.45 Bn | 1.62 Bn | -18.92% |
| 4 | Takeda Pharmaceutical | 27.59 Bn | 23.53 Bn | 4.39 Bn | -44.64% |
| 5 | United Therapeutics | 23.19 Bn | 21.04 Bn | 648.10 Mn | 0.68% |
| 6 | RedHill Biopharma | 20.53 Bn | 20.53 Bn | - | - |
| 7 | Viatris | 20.27 Bn | 18.46 Bn | 1.16 Bn | -27.74% |
| 8 | Neurocrine Biosciences | 18.00 Bn | 16.69 Bn | 800.70 Mn | 46.56% |
| 9 | Elanco Animal Health | 12.65 Bn | 12.22 Bn | 785.00 Mn | 39.19% |
| 10 | Medicure | 8.77 Mn | 7.64 Mn | 2.57 Mn | -131.46% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -131.46% |
| Sep 30, 2025 | -33.33% |
| Jun 30, 2025 | -35.04% |
| Mar 31, 2025 | 40.72% |
| Sep 30, 2024 | -32.60% |
| Jun 30, 2024 | -27.22% |
| Mar 31, 2024 | -36.68% |
| Dec 31, 2023 | 40.04% |
| Sep 30, 2023 | -19.74% |
| Jun 30, 2023 | 38.04% |
| Mar 31, 2023 | 30.23% |
| Sep 30, 2022 | 33.20% |
| Jun 30, 2022 | 31.82% |
| Mar 31, 2022 | 23.54% |
| Sep 30, 2021 | -26.08% |
| Jun 30, 2021 | 29.45% |
| Mar 31, 2021 | -18.55% |
| Sep 30, 2020 | -70.87% |
| Jun 30, 2020 | 37.68% |
| Mar 31, 2020 | -19.36% |